At $17,000 a month, Erbitux is one of the most expensive cancer drugs ever made. For the record, it is not the most expensive. That distinction is currently held by Zevalin, a $24,000-a-month treatment for a relatively rare type of lymphoma.
Have you checked your policy limits lately?